Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.

Clinical trial NCT02663102 · COMPLETED

Trial details

NCT number: NCT02663102
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza, Human

Start date: 2016-10-20
Primary completion: 2021-02-05
Enrollment: 1388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.